Page last updated: 2024-11-01

norfloxacin and Aqueductal Stenosis

norfloxacin has been researched along with Aqueductal Stenosis in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
" With the present dosage regimen, CSF quickly attains therapeutic levels of pefloxacin."1.27Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man. ( Chazal, J; Djebbar, F; Dow, J; Frydman, AM; Gaillot, J; Janny, P; Woehrle, R, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dow, J1
Chazal, J1
Frydman, AM1
Janny, P1
Woehrle, R1
Djebbar, F1
Gaillot, J1

Other Studies

1 other study available for norfloxacin and Aqueductal Stenosis

ArticleYear
Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl B

    Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Hydrocephalus; Infusi

1986